115 related articles for article (PubMed ID: 12355811)
41. Comparison between somatostatin analogues and ACE inhibitor in the NOD mouse model of diabetic kidney disease.
Segev Y; Eshet R; Rivkis I; Hayat C; Kachko L; Phillip M; Landau D
Nephrol Dial Transplant; 2004 Dec; 19(12):3021-8. PubMed ID: 15494355
[TBL] [Abstract][Full Text] [Related]
42. Changing concepts of the pathogenesis of diabetic nephropathy.
Wilion F; Bailie MD
N Y State J Med; 1990 Apr; 90(4):185-9. PubMed ID: 2185442
[No Abstract] [Full Text] [Related]
43. [Course and treatment of diabetic nephropathy].
van Gaal L; Moeremans M; de Leeuw I; Bekaert J
Ned Tijdschr Geneeskd; 1986 Feb; 130(8):348-51. PubMed ID: 3960177
[No Abstract] [Full Text] [Related]
44. [Urinary fibronectin degradation products].
Tada H; Kuboki K; Isogai S
Nihon Rinsho; 1998 Jan; 56 Suppl 3():354-9. PubMed ID: 9513442
[No Abstract] [Full Text] [Related]
45. [Measurement of urinary nitric oxide (NO) in patients with diabetes mellitus].
Shiraishi Y; Ishibashi F
Nihon Rinsho; 1998 Jan; 56 Suppl 3():395-9. PubMed ID: 9513450
[No Abstract] [Full Text] [Related]
46. [alpha 1-Acido glycoprotein].
Suehiro T; Hashimoto K
Nihon Rinsho; 1998 Jan; 56 Suppl 3():386-9. PubMed ID: 9513448
[No Abstract] [Full Text] [Related]
47. [Acid soluble protein].
Oshima I
Nihon Rinsho; 1998 Jan; 56 Suppl 3():283-91. PubMed ID: 9513431
[No Abstract] [Full Text] [Related]
48. [Urinary transferrin].
Misaki M; Tanaka T; Ezaki J; Sumida Y; Yano Y
Nihon Rinsho; 1998 Jan; 56 Suppl 3():297-302. PubMed ID: 9513433
[No Abstract] [Full Text] [Related]
49. [Proteoglycans].
Murata K
Nihon Rinsho; 1998 Jan; 56 Suppl 3():322-8. PubMed ID: 9513437
[No Abstract] [Full Text] [Related]
50. Urinary type-IV collagen.
Tomino Y
Contrib Nephrol; 2001; (134):85-7. PubMed ID: 11665294
[No Abstract] [Full Text] [Related]
51. [Polymorphonuclear leukocyte elastase].
Uehara Y; Sato N; Mori M
Nihon Rinsho; 1998 Jan; 56 Suppl 3():241-5. PubMed ID: 9513423
[No Abstract] [Full Text] [Related]
52. [Serum laminin and collagen in diabetes mellitus].
Tomono T; Kato N; Ohno T; Utsugi T; Kawazu S
Nihon Rinsho; 1998 Jan; 56 Suppl 3():135-43. PubMed ID: 9513404
[No Abstract] [Full Text] [Related]
53. Measurement of mouse urinary type IV collagen using time-resolved fluoroimmunoassay.
Kobayashi M; Kimura H; Liao J; Abe M; Hirose S; Tomino Y
Anal Sci; 2003 Feb; 19(2):205-10. PubMed ID: 12608746
[TBL] [Abstract][Full Text] [Related]
54. [Urinary angiotensinogen].
Araki S; Uzu T
Nihon Rinsho; 2010 Nov; 68 Suppl 9():437-40. PubMed ID: 21661180
[No Abstract] [Full Text] [Related]
55. [Glycylprolyl dipeptidyl aminopeptidase (GP-DAP)].
Matsuoka T; Himei H
Nihon Rinsho; 1998 Jan; 56 Suppl 3():336-40. PubMed ID: 9513439
[No Abstract] [Full Text] [Related]
56. Type IV collagen and diabetic kidney disease.
Miner JH
Nat Rev Nephrol; 2020 Jan; 16(1):3-4. PubMed ID: 31728033
[No Abstract] [Full Text] [Related]
57. [Tissue inhibitors of metalloproteinases (TIMPs) in urine].
Kanauchi M
Nihon Rinsho; 1998 Jan; 56 Suppl 3():416-8. PubMed ID: 9513454
[No Abstract] [Full Text] [Related]
58. [Kappa light chain].
Ieki Y; Takazakura E; Ohsawa K
Nihon Rinsho; 1998 Jan; 56 Suppl 3():347-53. PubMed ID: 9513441
[No Abstract] [Full Text] [Related]
59. Haemoglobin as a marker of fibrosis in early diabetic kidney disease.
Faivre A; de Seigneux S
Nephrol Dial Transplant; 2022 Feb; 37(3):403-404. PubMed ID: 34383946
[No Abstract] [Full Text] [Related]
60. Effects of diabetes on cardiovascular drug metabolism. Emerging clinical implications.
Preston RA; Epstein M
Diabetes Care; 1999 Jun; 22(6):982-8. PubMed ID: 10372252
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
